Combination immunotherapy is positioned to be the future of immuno-oncology drug development. Recent research shows that combining cancer immunotherapy with other therapies can product impressive results particularly in cancers that have shown limited to no response to immunotherapy.
This Research arc supplement by Cell Press provides a collection of articles that highlight different combinatorial approaches. Some of the articles include:
Interested in learning more? Complete the form below to download the article!